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Abstract 
This study was implemented at the University of Khartoum to investigate the 
protective effect of camel milk mixed with camel urine against alco-
hol-induced liver damage in Wistar albino rats. The reasons for combining 
camel milk and urine together are because that in Sudan this combination is 
used extensively in traditional medicine and they claimed that this combina-
tion cures a lot of diseases including liver disease and jaundice; 25 Wister Al-
bino rats of both sexes were brought and divided into 5 groups. Group 1 
(control group) received normal saline, group 2 received ethanol 10% at dose 
of (0.5 g/100g body weight) and group 3 rats received Silymarin (5 mg/100g 
body weight) plus ethanol 10% (0.5 g/100g). Group 4 received a mixture of 
camel milk and urine (1:1) at the rate of 2 ml/100g and group 5 rats were ad-
ministered with the mixture of camel’s milk and urine as in group 4 plus 
ethanol 10% (0.5 g/100g). All treatments given by an oral intubation, experi-
ment lasts for 28 days, rats were euthanized, serum samples and liver sections 
obtained. Oral administration of 10% ethanol (0.5 g/100g) induced liver 
damage which was clear in group 2 in a form of generalized necrosis, fatty 
change and congestion, beside high elevation of serum enzymes (AST, ALT, 
and ALP). Giving camel’s milk and urine mixture to group 5 with ethanol 
10% (0.5 g/100g), resulted in significant reduction of levels of serum enzymes 
(AST, ALT, and ALP) and in stabilization of serum metabolites (total protein, 
albumin and bilirubin). The degree of reduction was lower when significantly 
compared to (Silymarin + ethanol) group, and all results were verified by the 
histopathological changes. Hepatoprotective effects of camel’s milk and urine 
mixture were recorded and this could be attributed to antioxidant activity or 
to its chelate effects on toxicants. Drinking raw camel milk and urine mixture, 
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it was used extensively in traditional medicine in Sudan and it was found safe 
without any ill effect. 
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1. Introduction 
Liver is the first organ to metabolize all foreign compounds and hence it’s sus-
ceptible to many different disorders [1]. Among the compounds provoking such 
disorders, alcohol is one of the main causes of end-stage liver damage in a form 
of cellular necrosis and it is the second most common reason for liver trans-
plantation in the United States [2]. Both acute and chronic ethanol consumption 
leads to formation of cytokines, especially TNF-alpha by hepatic Kupffer cells, 
the increase in tissue lipid peroxidation and the depletion in the tissue gluta-
thione (GSH) [3], all this elements contributing to significant liver injury [4]. 
Moreover, alcoholic liver damages are related to the increase of serum levels of 
many biochemical markers like aspartate transaminase (AST), alanine trans-
aminase (ALT), serum alkaline phosphatase (ALP), triglycerides, cholesterol and 
bilirubin [5].  
In a context of low efficiency of available medical treatments for the liver pro-
tection from damage or help to regenerate hepatic cells, there is urgent need, 
therefore, for effective drugs to replace and supplement those in current use [6] 
[7] [8]. In spite of lack of clinical studies, camel milk and urine are regarded tra-
ditionally as a high quality drink and since ancient times people use them for 
curing a number of diseases [9] [10]. It has been reported that, the camel’s milk 
and urine has been used to cure diseases caused by chronic imbalance of the liv-
er [11] [12]. 
In-vivo, designed series of experiments in which mixture of camel urine and 
milk was given to Albino mice showed no effects on the normal liver and sto-
mach [13], this indicated the biological effect of the mixture is safe product. 
Therefore, the aims of this study were to evaluate the protective effect of the 
mixture of camel’s milk and urine on alcohol-induced hepatotoxicity in rats and 
to make more considerable pharmacological and clinical investigation on the 
therapeutic activity of this mixture. 
2. Materials and Methods 
2.1. Experimental Animals 
25 Wistar albino rats of both sexes weighing 85 - 105 g were used. They were 
obtained from the Animal House of the Veterinary Research Institute, Animal 
Resources Research Corporation, Soba, Khartoum. Rats kept within the premises 
of the Department of Pharmacology and Toxicology, Faculty of Veterinary 
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Medicine, University of Khartoum. After one week adaptation period, housed in 
cages, maintained in a light room under normal environmental conditions with 
temperature (28˚C ± 2˚C) plus relative humidity (61%), with free access to water 
and food, they were divided into 5 groups. All rats were apparently healthy and 
identified by color tail marks. The research was carried out according to the 
rules governing the use of laboratory animals as acceptable international. 
2.2. Collection of Camel’s Milk and Urine 
Fresh milk was collected from female camels of different ages and lactation pe-
riods during early morning milking time, while fresh urine from young female 
camels (Bekra) (6 month up to 3 years old) was collected early morning during 
normal urination from Camel Research Centre, University of Khartoum, this 
was done daily for 28 days during all experiment period. 
2.3. Experimental Design 
The rats were divided into 5 groups of 5 rats each: 
1) Control rats (group 1) received normal saline orally;  
2) Ethanol group (group 2) received orally ethanol 10% only at a dose of 0.5 
g/100g body weight as single dose/day;  
3) Ethanol plus Silymarin rats (group 3) received orally Silymarin as a hepa-
toprotective drug (5 mg/100g body weight), and after 3 hours received ethanol 
10% (0.5 g/100g body weight); 
4) Mixture of Camel’s milk and Camel’s urine (CMCU) rats (group 4) re-
ceived camel’s milk (CM) and urine (CU) (1:1) at the rate of 2 ml/100g by an 
oral intubation;  
5) Ethanol plus CMCU rats (group 5) were administered with the mixture of 
camel’s milk and urine as same in group 4 and after 3 hours received orally 
ethanol 10% (0.5 g/100g). 
All treatments were continued for 28 days. 
2.4. Serum Enzymes and Serum Metabolites 
Blood samples were collected from the orbital plexus of rats on days zero, 15 and 
29 of the experiment. The markers of liver damages as aspartate aminotransfe-
rase (AST), alanine amino transferase (ALT) and alkaline phosphatase (ALP) 
were determined [14]. In addition, serum total protein, albumin and bilirubin 
concentrations were also determined [15]. All samples were analyzed by using 
commercial kits (Randox Laboratories Ltd., U.K.). 
2.5. Histopathological Methods 
Clinical signs were recorded and the postmortem examination was carried after 
slaughtering of the rats at day 29. Then 25 livers specimens were collected and 
fixed in 10% buffered formal saline, and transported to laboratory for histopa-
thological processing and investigations. Specimens embedded in paraffin wax 
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sectioned at 5 μm and stained routinely with Hematoxylin and Eosin (H & E) 
using Mayer’s Hemalum. 
2.6. Statistical Analysis 
Data were entered and analyzed using SAS statistical package. Numerical data 
were expressed as means and standard errors. Significance of difference between 
means were tested by one-way ANOVA, depending on the number of compared 
groups; with a p value of ≤0.05 considered statistically significant [16]. 
3. Results 
3.1. Clinical Signs 
There were no abnormal clinical signs in all groups except Ethanol rats (group 2) 
where the rats presented depression and general unthriftiness from day 13 
throughout. 
3.2. Postmortem Findings 
Regarding the pathological lesions of liver, the rats from Ethanol group showed 
fatty changes, slight congestion and adhesion in lobes, while in group 4 (CMCU 
group) and Ethanol plus CMCU group, no postmortem changes were observed. 
A slight fatty change of liver with grey spots was observed in Ethanol plus Sily-
marin group. 
3.3. Changes in Serum Enzymes 
Table 1, demonstrated the changes in serum enzymes as; in intoxicated rats 
(group 2), the activities of enzymes AST, ALT and ALP were significantly in-
creased when compared to the untreated control groups while the administra-
tion of camel’s milk and urine CMCU to intoxicated rats (group 5) resulted in 
significant amelioration of the levels of the enzymes AST, ALT, and ALP, when 
compared to the group treated with ethanol (group 2). Moreover, this improve-
ment is higher in Ethanol plus CMCU rats (group5) than in rats treated with Si-
lymarin and ethanol (group 3). 
3.4. Changes in Serum Metabolites Parameters 
Table 2 showed the changes in serum metabolites in treated groups which re-
vealed that, in rats treated with ethanol only (group 2) the concentration of total 
protein, albumin and bilirubin were significantly increased when compared to 
the untreated control group 1. Administration of camel milk and urine CMCU 
to intoxicated rats (group 4) resulted in significant fall in the concentration of 
total protein, albumin and bilirubin, when compared to the group treated with 
ethanol (group 2) even more than Ethanol plus Silymarin rats (group 3). 
3.5. Histopathological Changes 
As showed in Figures 1(a)-(d), no pathological changes were observed in con- 
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(a)                   (b)                 (c)                  (d) 
Figure 1. Histopathological changes in livers of rats treated with ethanol, camel milk and 
urine plus Silymarin (Arrowa indicate the followings): (a) = Section of liver cells of Etha-
nol rats (Group 2) (10% ethanol at 5 g/kg), showing centrilobular necrosis and lympho-
cytic infiltration; (b) = Section of liver cells of CMCU rats (Group 4) treated with mixture 
of camel milk and urine at “2 ml/100gm B. W.”, showing almost normal architecture; (c) 
= Section of liver cells of Ethanol/CMCU rats (Group 5) which treated with mixture of 
camel milk & urine at “2 ml/100gm”. + 10% ethanol 5 g/kg, showing slight fatty change & 
lymphocytic infiltration; (d) = Section of liver cells of Ethanol/Silymarin rats (Group 3) 
treated with Silymarin at 50 mg/kg + 10% ethanol at 5 g/kg, showing generalized fatty 
change. 
 
Table 1. Changes in serum enzymes in rats treated with mixture of camel milk and urine 
against ethanol induced-liver damage. 
AST (SGOT) U/I (Means ± S.E)  
Groups Day 29 Day 15 Day Zero 
38.4 ± 0.98 c 37.26 ± 1.15 c 39.34 ± 1.23 a Control rats (Group 1) 
62.6 ± 2.01 a 63.8 ± 3.02 a 38.02 ±1.71ab Ethanol rats (Group 2) 
54.2 ± 2.27 b 53.2 ± 1.98 b 35.34 ± 0.83 b Ethanol/Silymarin rats (Group 3) 
37.4 ± 0.87 c 38.08 ± 1.37 c 36.02 ±0.68ab CMCU rats (Group 4) 
50.4 ± 1.69 b 51.8 ± 2.06 b 35.34 ± 0.83b Ethanol/CMCU rats (Group 5) 
ALT (SGPT) U/I (Means ± S.E) 
Groups 
Day 29 Day 15 Day Zero 
6.4 ± 0.51 c 6 ± 0.71 c 5 ± 1.14 a Control rats (Group 1) 
16.8 ± 0.86 a 15.4 ± 0.87 a 4.6 ± 0.75 a Ethanol rats (Group 2) 
16.2 ± 0.37 a 14.8 ± 0.37 a 3.4 ± 0.68 a Ethanol/Silymarin rats (Group 3) 
5.6 ± 0.51 c 5.4 ± 0.93 c 4.6 ± 0.74 a CMCU rats (Group 4) 
14.2 ± 0.37 b 12.6 ± 0.68 b 2.6 ± 0.24 a Ethanol/CMCU rats (Group 5) 
(ALP) U/I (Means ± S.E) 
Groups 
Day 29 Day 15 Day Zero 
76.2 ± 1.24 b 76.2 ± 1.39 bc 80.4 ± 2.06 a Control rats (Group 1) 
79.8 ± 0.66 a 79.4 ± 0.51 a 79.2 ± 1.16 a Ethanol rats (Group 2) 
77.8 ± 0.37 ab 78 ± 0.70 ab 79.8 ± 1.16 a Ethanol/Silymarin rats (Group 3) 
76.8 ± 0.58 b 77 ± 0.71 abc 78.4 ± 1.44 a CMCU rats (Group 4) 
76.2 ± 0.37 b 74.8 ± 0.37 c 77.6 ± 0.93 a Ethanol/CMCU rats (Group 5) 
Group 1 (Control); Group 2 (10% Ethanol at 5 g/kg); Group 3 (Silymarin at 50 mg/kg + 10% Ethanol at 5 
g/kg); Group 4 (1:1 mixture of camel milk and urine at “2 ml/100gm B. W.”); Group 5 (1:1 mixture of camel 
milk and urine at “2 ml/100gm B. W.” + 10% Ethanol at 5 g/kg). Values are means ± standard errors. 
Means in the same column with the same letters are not significantly different. (P < 0.05). 
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Table 2. Changes in serum metabolites concentration of rats treated with mixture of ca-
mel milk and urine against ethanol induced-liver damage. 
Total protein g/dl (Means ± S.E) 
Groups 
Day 29 Day 15 Day zero 
5.26 ± 0.15 c 5.26 ± 0.14 b 5.5 ± 0.17 a Control rats (Group 1) 
5.7 ± 0.07 a 5.66 ± 0.09 a 5.46 ± 0.12 a Ethanol rats (Group 2) 
5.6 ± 0.05 ab 5.66 ± 0.09 a 5.58 ± 0.09 a Ethanol/Silymarin rats (Group 3) 
5.36 ± 0.05 bc 5.36 ± 0.10 ab 5.58 ± 0.10 a CMCU rats (Group 4) 
5.42 ± 0.06 bc 5.5 ± 0.07 ab 5.6 ± 0.05 a Ethanol/CMCU rats (Group 5) 
Albumin g/dl (Means ± S.E) 
Groups 
Day 29 Day 15 Day Zero 
2.48 ± 0.14 bc 2.34 ± 0.15 b 2.78 ± 0.10 a Control rats (Group 1) 
2.76 ± 0.05 a 2.74 ± 0.07 a 2.58 ± 0.13 a Ethanol rats (Group 2) 
2.7 ± 0.05 ab 2.72 ± 0.07 a 2.6 ± 0.07 a Ethanol/Silymarin rats (Group 3) 
2.42 ± 0.06 c 2.5 ± 0.12 ab 2.68 ± 0.10 a CMCU rats (Group 4) 
2.5 ± 0.05 bc 2.6 ± 0.07 ab 2.6 ± 0.05 a Ethanol/CMCU rats (Group 5) 
Billirubin mg/dl (Means ± S.E) 
Groups 
Day 29 Day 15 Day Zero 
0.22 ± 0.04 c 0.3 ± 0.07 b 0.58 ± 0.13 a Control rats (Group 1) 
0.56 ± 0.05 a 0.54 ± 0.05 a 0.4 ± 0.15 ab Ethanol rats (Group 2) 
0.46 ± 0.05 ab 0.38 ± 0.04 b 0.28 ± 0.13 ab Ethanol/Silymarin rats (Group 3) 
0.28 ± 0.04 c 0.3 ± 0.04 b 0.14 ± 0.02 b CMCU rats (Group 4) 
0.34 ± 0.02 bc 0.32 ± 0.04 b 0.32 ± 0.15 ab Ethanol/CMCU rats (Group 5) 
Group 1 (Control); Group 2 (10% Ethanol at 5 g/kg); Group 3 (Silymarin at 50 mg/kg + 10% Ethanol at 5 
g/kg); Group 4 (1:1 mixture of camel milk and urine at “2 ml/100gm B. W.”); Group 5 (1:1 mixture of camel 
milk and urine at “2 ml/100gm B. W.” + 10% Ethanol at 5 g/kg). Values are means ± standard errors. 
Means in the same column with the same letters are not significantly different. (P < 0.05). 
 
trol group while liver damage was seen in a form of centrilobular necrosis and 
lymphocytic infiltration in Ethanol groups. In CMCU rats there was almost 
normal architecture. In Ethanol plus CMCU group, there was slight fatty change 
and lymphocytic infiltration, while in Ethanol plus Silymarin group there was 
generalized fatty change. 
4. Discussion 
In the current study in which we used the ethanol as a model for chronic hepa-
totoxicity in rats, a high increase in serum activities of liver enzymes AST, ALT, 
ALP and metabolites as total protein, albumin and bilirubin in rats treated with 
ethanol 10%, was recorded indicating that the dose of 0.5 g/100g can produce 
chronic liver toxicity, this finding was confirmed by histopatholohical finding as 
centrilobular necrosis and lymphocytic infiltration (Figure 1(a)). Our results 
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were similarly consistent with the findings of many authors who reported that, 
alcohol (10% ethanol) intoxication significantly increased AST and ALT besides 
arising of the histopathology of hepatic injury [17]. Also, they indicated that ex-
posure of hepatocytes to ethanol alters the membrane structure and functions by 
increasing the leakage of enzymes into the circulation [18]. On the other hand, 
some of them reported that, excess alcohol consumption has been linked with 
altered liver metabolism and liver damage [19]. At reverse, the results obtained 
by others found a decrease in serum total proteins and albumin in ethanol ad-
ministered rats [20]. They suggested that this decrease was due to a reduction in 
the functional ability of liver by ethanol. 
In our study treated rats showed, a decrease in serum activities of liver en-
zymes AST, ALT, ALP besides fall in levels of serum total protein, albumin and 
bilirubin, maintained near the normal range, especially in rats treated with ca-
mel’s milk and urine plus alcohol. The degree of reduction was much lower than 
Ethanol plus Silymarin group. This could indicate improvement of liver function 
and protection from alcohol toxicity. The same results were reached by using 
camel’s milk only as protection against CCL4 liver damage protocol instead of 
using alcohol [21]. Our findings were confirmed by detection of necrosis, apop-
tosis, fatty accumulation and inflammatory cells infiltration on histological 
findings in ethanol treated group, and clearly alleviated in protected rats by ca-
mel’s milk and urine CMCU (groups 4) while there were no pathological 
changes in group 5. These results were in agreement with those who suggested 
that camel’s milk intake may play an important role in ameliorating alcoholic 
liver injury after using ethanol 56% at a dose of 6 g/kg/day [22], and also with 
the others who investigated the effects of camel’s milk on improving the hepatic 
biochemical and cellular alterations induced by a high-fat, cholesterol-rich diet 
[23]. The same findings were obtained from our previous study with camel’s 
urine alone against alcohol induced liver damage in rats [24]. Protection of the 
liver from chemical injuries was produced by different agents such as herbs as it 
was reported by many authors who found that if the rats pre-treated with some 
herbal extracts against CCL4 or paracetamol instead of camel’s milk and urine 
against ethanol 10%, that will significantly controlled the changes in the bio-
chemical parameters, and exhibited a sharp decrease of the levels in the serum 
enzymes indicators of suffering liver [25]-[30]. Also similar results obtained by 
using montelukast sodium (Cysteinyl-leukotriene type 1 selective receptor anta-
gonist) as hepatoprotective instead of camel’s milk and urine [31].  
The hepatoprotective effects of camel’s milk and urine could be attributed to 
its possible chelating effects on toxicants specially alcohol [32], or to the high le-
vels of Vitamins C, B2, E, magnesium and other trace elements on camel’s milk 
and urine which may play a major role as antioxidants [33] and found to be 
useful in preventing the tissues injury caused by toxic agent [34]. The biological 
function of camel urine was supported in literature by many researchers [35] 
[36] [37] [38].  
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5. Conclusion 
The oral administration of ethanol by a dose of 0.5 g/100g induced chronic 
damage of liver cells which was manifested biochemically in rats. Camel’s milk 
and urine CMCU induced significant decreases in serum enzymes, indicators of 
liver suffering, testifying of a certain hepato-protective effect against chronic 
toxicity induced by ethanol even higher than using the reference drug (Silyma-
rin). However, further studies are necessary, especially clinical investigations in 
order to confirm the potential effect of camel’s milk mixed with urine as benefi-
cial drink for the prevention of chronic liver toxicity. We recommend for future 
work purifying the macromolecules involved in the protective activity of camel 
milk and urine mixture, and test the protective effect for the purified portion. 
Conflict of Interest 
The authors declare that there are no conflicts of interest. 
Authors’ Contributions 
Ahmed E. Elhag and Samia M. A. El Badwi carried out the whole experiment in-
cluding the lab, and data analysis in Sudan, Bernard Faye contributed in writing 
the manuscript and publication process. All authors critically reviewed the data 
and the manuscript. 
References 
[1] Sarkar, M.K., Sarkar, K., Bhattacharjee, R., Chatterjee, M. and Sil, P.C. (2005) Cura-
tive Role of the Aqueous Extract of the Herb, Phyllanthus niruri, against Nimesulide 
Induced Oxidative Stress in Murine Liver. Biomedical Research, 16, 171-176. 
[2] Mandayam, S., Jamal, M.M. and Morgan, T.R. (2004) Epidemiology of Alcoholic 
Liver Disease. Seminars in Liver Disease Journal, 24, 217-232. 
https://doi.org/10.1055/s-2004-832936 
[3] Sandy, O. and Ben, H.C. (1998) The Effects of Glutathione Glycoside in Acetami-
nophen-Induced Liver Cell Necrosis. Experimental and Molecular Pathology Jour-
nal, 65, 15-24. https://doi.org/10.1006/exmp.1998.2221 
[4] Zakhari, S. and Li, T.K. (2007) Determinants of Alcohol Use and Abuse: Impact of 
Quantity and Frequency Patterns on Liver Disease. Hepatology Journal, 46, 
2032-2039. https://doi.org/10.1002/hep.22010 
[5] Lu, Y. and Cederbaum, A.I. (2008) CYP2E1 and Oxidative Liver Injury by Alcohol. 
Free Radical Biology and Medicine Journal, 44, 723-738. 
https://doi.org/10.1016/j.freeradbiomed.2007.11.004 
[6] Lee, C.H., Park, S.W., Kim, Y.S., Kang, S.S., Kim, J.A., Lee, S.H. and lee, S.M. (2007) 
Protective Mechanism of Glycyrrhizin on Acute Liver Injury Induced by Carbon 
Tetra Chloride in Mice. Biological and Pharmaceutical Bulletin Journal, 30, 
1898-1904. https://doi.org/10.1248/bpb.30.1898 
[7] Chattopadhyay, R.R. (2003) Possible Mechanism of Hepatoprotective Activity of 
Azadirachta indica Leaf Extract: Part II. Journal of Ethnopharmacology, 89, 
217-219. https://doi.org/10.1016/j.jep.2003.08.006 
[8] Adewusi, E.A. and Afolayan, A.J. (2010) A Review of Natural Products with Hepa-
A. E. Elhag et al. 
 
 
DOI: 10.4236/abb.2017.810027 386 Advances in Bioscience and Biotechnology 
 
toprotective Activity. Journal of Medicinal Plants Research, 4, 1318-1334. 
[9] Shabo, Y., Barzel, R., Margoulis, M. and Yagil R. (2005) Camel Milk for Food Aller-
gies in Children. Israel Medical Association Journal, 7, 796-259. 
[10] Redwan, R.M. and Tabll, A. (2007) Camel Lactoferrin Markedly Inhibits Hepatitis C 
Virus Genotype 4 Infection of Human Peripheral Blood Leucocytes. Journal of 
Immunoassay Immunochemistry, 28, 267-277.  
https://doi.org/10.1080/15321810701454839 
[11] Haddad, G.F. (2006) Camel’s Milk and Urine Hadiths.  
[12] AL-Hashem, F. (2009) Camel Milk Protects against Aluminum Chloride-Induced 
Toxicity in the Liver and Kidney of White Albino Rats. American Journal of Bio-
chemistry and Biotechnology, 5, 98-108. https://doi.org/10.3844/ajbbsp.2009.98.108 
[13] EL-Elyani, R.A. and Khalifa, S.A.M. (2006) Histological Studies on the Effect of 
Camel’s Urine and Milk on Stomach of Albino Mice. Saudi Journal of Biological 
Sciences, 13, 2. 
[14] Young, D.S. (1990) Effects of Drugs on Clinical Laboratory Tests. 3rd Edition, 
AACC Press, Washington DC, 6-12. 
[15] Stein, E.A. (1986) Text Book of Clinical Chemistry. Tietz, N.W., Ed., W.B. Saunders 
Company, Philadelphia, 879-886. 
[16] Mendenhall, W. (1971) Introduction to Probability and Statistics. 3rd Edition, 
Wadsworth Publishing Company, Belmont, California, 35-38. 
[17] Yoo, J.-H., Kang, K., Yun, J.H., Kim, M.A. and Nho, C.W. (2014) Crepidiastrum 
denticulatum Extract Protects the Liver against Chronic Alcohol-Induced Damage 
and Fat Accumulation in Rats. Journal of Medicinal Food, 17, 432-438.  
https://doi.org/10.1089/jmf.2013.2799 
[18] Rajakrishnan, V. and Menon, V.P. (2001) Potential Role of Antioxidants during 
Ethanol Induced Changes in the Fatty Acid Composition and Arachidonic Acid 
Metabolites in Male Wistar Rats. Cell Biology and Toxicology Journal, 17, 11-22.  
https://doi.org/10.1023/A:1010998929785 
[19] Das, D., Mukherjee, M.M., Das, A.S. and Mitra, C. (2005) Aqueous Extract of Black 
Tea Camellia sinensis Prevents Chronic Ethanol Toxicity. Current Science Journal, 
88, 952-961. 
[20] Ahmed, B., Alam, T., Varshney, M. and Khan, S.A. (2002) Hepatoprotective Activi-
ty of Tow Plants Belonging to the Apiaceae and the Euphorbiaceae Family. Journal 
of Ethnopharmacology, 79, 313-316.  
https://doi.org/10.1016/S0378-8741(01)00392-0 
[21] Khan, A.A. and Alzohairy, M.A. (2011) Hepatoprotective Effects of Camel Milk 
against CCL4 Induced Hepatotoxicity in Rats. Asian Journal of Biochemistry, 6, 
171-180. https://doi.org/10.3923/ajb.2011.171.180 
[22] Darwish, H.A., Abd Raboh, N.R. and Mahdy, A. (2012) Camel’s Milk Alleviates Al-
cohol-Induced Liver Injury in Rats. Food and Chemical Toxicology, 50, 1377-1383.  
https://doi.org/10.1016/j.fct.2012.01.016 
[23] Korish, A. and Arafah, M. (2013) Camel Milk Ameliorates Steatohepatitis, Insulin 
Resistance and Lipid Peroxidation in Experimental Non-Alcoholic Fatty Liver Dis-
ease. BMC Complementary and Alternative Medicine, 13, 264-276.  
https://doi.org/10.1186/1472-6882-13-264 
[24] Elhag, A.E., El Badwi, S.M.A. and Mustafa, A.B. (2016) Hepatoprotective Effect of 
Urine of One-Humped Camel (Camelus dromedarius) against Ethanol Induced 
Liver Damage in Rats. International Journal of Pharmaceutical Chemistry, 5, 1-8. 
A. E. Elhag et al. 
 
 
DOI: 10.4236/abb.2017.810027 387 Advances in Bioscience and Biotechnology 
 
[25] Kumar, S.S., Kumar, B.R. and Mohan, G.K. (2009) Hepatoprotective Effect of Tri-
chosanthes cucumerina Var cucumerina L. on Carbon Tetrachloride Induced Liver 
Damage in Rats. Journal of Ethnopharmacology, 123, 347-350.  
https://doi.org/10.1016/j.jep.2009.02.023 
[26] Shen, X., Tang, Y., Yang, R., Yu, L., Fang, T. and Duan, J.A. (2009) The Protective 
Effect of Zizyphus jujube Fruit on Carbon Tetrachloride-Induced Hepatic Injury in 
Mice by Anti-Oxidant Activities. Journal of Ethnopharmacology, 122, 555-560.  
https://doi.org/10.1016/j.jep.2009.01.027 
[27] Elhag, R.A.M., El Badwi, S.M.A., Bakhiet, A.O. and Galal, M. (2011) Hepatoprotec-
tive Activity of Solanum nigrum Extracts on Chemically Induced Liver Damage in 
Rats. Journal of Veterinary Medicine and Animal Health, 3, 45-50  
[28] Ali, S.A.M., El Badwi, S.M.A., Idris, T.M. and Osman, K.M. (2011). Hepatoprotec-
tive Activity of Aqueous Extract of Khaya senegalensis Bark in Rats. Journal of Me-
dicinal Plant Research, 5, 5863-5866.  
[29] El Badwi, S.M.A., El Bagir, N.M. and Amin, A.E. (2013) Protective Effect of Etha-
nolic Extract of Tamarindus indica against CCl4 Induced Liver Damage in Rats. 
Australian Journal of Basic and Applied Sciences, 7, 813-818. 
[30] Mohamed, H.S.A.A., Abdelgadir, W.S. and El Badwi, S.M.A. (2015) Hepatoprotec-
tive Activity of the Ethanol Extract of Cassia obtusifolia Seeds Against Paraceta-
mol-Induced Liver Damage in Rats. European Journal of Pharmaceutical and Med-
ical Research, 1, 277-289. 
[31] Cuciureanu, M., Caruntu, I.D., Paduraru, O., Stoica, B., Jerca, L., Crauciuc, E. and 
Nechifor, M. (2009) The Protective Effect of Montelukast sodium on Carbon Te-
trachloride Induced Hepatopathy in Rats. Prostaglandins Other Lipid Mediat, 88, 
82-88. https://doi.org/10.1016/j.prostaglandins.2008.10.004 
[32] Zhang, H., Yao, J., Zhao, D., Liu, H., Li, J. and Guo, M. (2005) Changes in Chemical 
Composition of Alxa Bactrian Camel Milk during Lactation. Journal of Dairy 
Science, 88, 3402-3410. https://doi.org/10.3168/jds.S0022-0302(05)73024-1 
[33] AL-Humaid, A.I., Mousa, H.M., El-Mergawi, R.A. and Abdel-Salam, A.M. (2010) 
Chemical Composition and Antioxidant Activity of Dates and Camel Milk Mixtures 
as a Protective Meal against Lipid Peroxidation in Rats. American Journal of Food 
Technology, 5, 98-108. https://doi.org/10.3923/ajft.2010.22.30 
[34] Knoess, K.H. (1979) Milk Production of the Dromedary. Proceeding of the IFS 
Symposium on Camels, Khartoum, 18-20 December 1979, 201-214. 
[35] Al-Yousef, N., Gaafar, A., Al-Otaibi, B., Al-Jammaz, I., Al-Hussein, K. and Abous-
sekhra, A. (2012) Camel Urine Components Display Anti-Cancer Properties in Vi-
tro. Journal of Ethnopharmacology, 143, 819-825.  
https://doi.org/10.1016/j.jep.2012.07.042 
[36] Alhaider, A.A., Abdel Gader, A.M. and Mousa, S.A. (2011) The Antiplateletive 
Properties of Camel Urine. The Journal of Alternative and Complementary Medi-
cine, 17, 803e808. 
[37] Alhaider, A.A., Abel Gader, A.G.M., Almeshal, N. and Saraswati, S. (2014) Camel 
Urine Inhibits Inflammatory Angiogenesis in Murine Sponge Implant Angiogenesis 
Model. Biomed Aging Pathology, 4, 9-16.  
https://doi.org/10.1016/j.biomag.2013.10.003 
[38] Alhaider, A.A., El Gendy, M.A., Korashy, H.M. and El-Kadi, A.O. (2011) Camel 
Urine Inhibits the Cytochrome P450 1a1 Gene Expression through an AhR-Dependent 
Mechanism in Hepa 1c1c7 Cell Line. Journal of Ethnopharmacology, 133, 184-190.  
https://doi.org/10.1016/j.jep.2010.09.012 
